company background image
NOVT logo

Novanta NasdaqGS:NOVT Voorraadrapport

Laatste prijs

US$174.22

Marktkapitalisatie

US$6.3b

7D

-1.2%

1Y

25.8%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Novanta Inc.

NasdaqGS:NOVT Voorraadrapport

Marktkapitalisatie: US$6.3b

NOVT Overzicht aandelen

Novanta Inc. levert samen met haar dochterondernemingen precisiegeneeskunde en -productie, medische oplossingen en robotica- en automatiseringsoplossingen in de Verenigde Staten en internationaal.

Over het bedrijf

Beloningen

Trading at 4.8% below our estimate of its fair value
Earnings are forecast to grow 35.49% per year

Risicoanalyse

Has a high level of debt

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth

Key Takeaways Focusing on medical devices with new products might significantly boost future revenue through innovation, aiming for notable revenue from new launches by 2025. Strategic acquisitions and emphasis on high-growth areas like robotics and precision medicine are poised to drive long-term growth and improve financial performance.
View narrative
US$181.00
FV
3.7% undervalued intrinsic discount
12.32%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative

Novanta Inc. Concurrenten

Badger Meter

NYSE:BMI

US$5.9b

National Instruments

NasdaqGS:NATI

US$8.0b

Itron

NasdaqGS:ITRI

US$5.0b

Vontier

NYSE:VNT

US$5.6b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Novanta
Historische aandelenkoersen
Huidige aandelenkoersUS$174.22
52 Week HoogtepuntUS$187.12
52 Week LaagUS$111.20
Bèta1.29
11 maand verandering-0.45%
3 maanden verandering2.37%
1 Jaar Verandering25.83%
33 jaar verandering-2.56%
5 jaar verandering118.87%
Verandering sinds IPO993.13%

Recent nieuws en updates

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02

Recent updates

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Aug 24
Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 24
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Feb 05
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Dec 29
Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Nov 20
Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Nov 01
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Oct 19
Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Sep 21
Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

Sep 06
Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Aug 19
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Jul 16
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

Jun 06
Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Apr 13
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Mar 29
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

Feb 27
Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Feb 12
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

Jan 12
Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Dec 28
We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

Nov 02
Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Oct 03
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Sep 19
With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Aug 23
Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance

Aug 09

Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Aug 03
Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

Jul 11
Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

At US$124, Is Novanta Inc. (NASDAQ:NOVT) Worth Looking At Closely?

Jun 09
At US$124, Is Novanta Inc. (NASDAQ:NOVT) Worth Looking At Closely?

Calculating The Fair Value Of Novanta Inc. (NASDAQ:NOVT)

May 10
Calculating The Fair Value Of Novanta Inc. (NASDAQ:NOVT)

Rendement voor aandeelhouders

NOVTUS ElectronicUS Markt
7D-1.2%-1.4%-1.6%
1Y25.8%32.5%30.8%

Rendement versus industrie: NOVT underperformed the US Electronic industry which returned 31.6% over the past year.

Rendement versus markt: NOVT underperformed the US Market which returned 30.6% over the past year.

Prijsvolatiliteit

Is NOVT's price volatile compared to industry and market?
NOVT volatility
NOVT Average Weekly Movement4.7%
Electronic Industry Average Movement6.4%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: NOVT has not had significant price volatility in the past 3 months compared to the US market.

Volatiliteit in de loop van de tijd: NOVT's weekly volatility (5%) has been stable over the past year.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19682,900Matthijs Glastrawww.novanta.com

Novanta Inc. levert samen met haar dochterondernemingen precisiegeneeskunde en -productie, medische oplossingen en robotica- en automatiseringsoplossingen in de Verenigde Staten en internationaal. Het bedrijf is actief in drie segmenten: Precisiegeneeskunde en Productie, Medische Oplossingen en Robotica en Automatisering. Het segment Precisiegeneeskunde en Productie biedt op fotonica gebaseerde oplossingen, waaronder laserscannen, straalgeleiding, CO2-laser, vastestoflaser, ultrasnelle laser en optische lichtmachines voor op fotonica gebaseerde toepassingen voor industriële verwerking, metrologie, medische en biowetenschappelijke beeldvorming, DNA-sequentiebepaling en medische laserprocedures.

Novanta Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Novanta zich tot de beurswaarde?
NOVT fundamentele statistieken
MarktkapitalisatieUS$6.26b
Inkomsten(TTM)US$62.17m
Inkomsten(TTM)US$899.85m

100.6x

Koers/Winstverhouding

7.0x

P/S-verhouding

Is NOVT overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
NOVT resultatenrekening (TTM)
InkomstenUS$899.85m
Kosten van inkomstenUS$502.60m
BrutowinstUS$397.25m
Overige uitgavenUS$335.09m
InkomstenUS$62.17m

Laatst gerapporteerde inkomsten

Jun 28, 2024

Volgende inkomensdatum

Nov 05, 2024

Winst per aandeel (EPS)1.73
Brutomarge44.15%
Nettowinstmarge6.91%
Schuld/Eigen Vermogen Verhouding68.7%

Hoe presteerde NOVT op de lange termijn?

Bekijk historische prestaties en vergelijking